Related Experiment Video
Updated: Sep 19, 2025

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
An Overlooked Family with a Rare Mutation for Fabry Disease
Gamze Babur Güler1, Arda Güler1, Abdullah Doğan1
1Department of Cardiology, Istanbul University of Health Sciences, Mehmet Akif Ersoy Thoracic Cardiovascular Surgery Training and Research Hospital, Istanbul, Türkiye.
Insights
Fabry disease, a rare genetic disorder, was diagnosed in a patient with heart valve issues and kidney failure. Family screening identified unaffected members, preventing future organ damage.
Area of Science:
- Genetics
- Rare Diseases
- Cardiology
Background:
- Fabry disease is a rare, multi-organ disorder caused by GLA gene mutations.
- Over 1,000 GLA gene mutations are known, but new discoveries are ongoing.
- Early diagnosis and intervention are crucial for managing Fabry disease.
Observation:
- A patient presented with heart valve disease and a history of kidney transplantation and hemodialysis.
- Clinical suspicion led to the diagnosis of Fabry disease.
- The significant impact of the disease on the patient's family was noted.
Findings:
- A rare GLA gene mutation was identified in the patient.
- This specific mutation is classified as a variant of uncertain significance (VUS) in some databases.
- Family screening successfully identified unaffected family members.
Implications:
- Early identification of unaffected family members can prevent or mitigate organ involvement.
- This case contributes valuable data to the genetic literature on Fabry disease.
- Understanding rare GLA mutations and their VUS classification is critical for accurate diagnosis and genetic counseling.
Abstract:
Fabry disease is a rare disorder characterized by multi-organ involvement, caused by mutations in the GLA gene. Although more than 1,000 mutations have been identified in the GLA gene, the discovery and detection of new mutations continue to enhance this dataset. We report a patient examined at our clinic for heart valve disease, who had a history of kidney transplantation and hemodialysis. With a high clinical suspicion, we diagnosed Fabry disease and will discuss its significant impact on the family. Effective family screening allowed us to identify unaffected family members, thus preventing or mitigating potential future organ involvement. Additionally, the mutation found in this family, although rarely reported before, is still described as a variant of uncertain significance (VUS) in some sources. We believe this finding will make a valuable contribution to genetic literature.
More Related Videos
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
06:41In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Inborn Errors of Metabolism
Animal Mitochondrial Genetics
Cystic Fibrosis: Management
Sinus disease and chronic...
Pedigree Analysis
Sex-linked Disorders